{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:51:41Z","timestamp":1781650301479,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yangzhou Science and Technology Plan Social Development Project","award":["YZ2025393"],"award-info":[{"award-number":["YZ2025393"]}]},{"name":"Scientific Research Project of Jiangsu Commission of Health","award":["ZD2022010"],"award-info":[{"award-number":["ZD2022010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Performing targeted biopsy (TB) first, followed by intraoperative frozen section examination (IFSE), and omitting systematic biopsy (SB) when prostate cancer is detected may reduce the number of unnecessary biopsy cores from SB while maintaining an equivalent prostate cancer detection rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients scheduled for mpMRI\/TRUS fusion biopsy due to a PIRADS score\u2009\u2265\u20094 were prospectively enrolled between October 2023 and November 2025. Patients were randomly assigned to a control group (TB\u2009+\u2009SB) or an observation group using a random number table. In the observation group, TB was performed first, and the obtained specimens were immediately subjected to IFSE. If the result was positive, no further cores were taken; if negative, SB was subsequently performed. The positive detection rate, complication rates, and post-radical prostatectomy (RARP) pathological findings were compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 195 and 187 patients were included in the control and observation groups, respectively. The overall positive biopsy rate was 80.51% (157\/195) in the control group and 78.61% (147\/187) in the observation group, with no significant statistical difference (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.645). The clinically significant prostate cancer (csPCa) detection rates were 67.69% (132\/195) and 69.52% (130\/187) in the control and observation groups, respectively, showing no significant difference (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.701). The mean number of biopsy cores was 23.89\u2009\u00b1\u20096.42 in the control group and 8.27\u2009\u00b1\u20098.90 in the observation group, which was significantly lower than the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). In the observation group, 50 patients (26.74%) underwent immediate additional SB, and 10 (5.35%) had Routine pathology positive for prostate cancer, including 5 with csPCa. The mean time to obtain the final pathology report was 0.025 (0.023,4) days in the observation group, significantly shorter than the 4 (4,5) days in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The VAS pain score was also significantly lower in the observation group compared to the control group (2.52\u2009\u00b1\u20091.52 vs. 2.91\u2009\u00b1\u20091.59,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014). Among patients who subsequently underwent RARP, there were no significant differences between the control and observation groups in terms of pathological upgrading\/downgrading (44.19% vs. 38.24%) or positive surgical margin rates (25.58% vs. 23.53%) (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For patients with suspected prostate cancer, the novel biopsy model based on IFSE may be a feasible option. It can maintain a comparable prostate cancer detection rate while significantly reducing the number of biopsy cores, and shows no oncological disadvantage at the time of RARP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15960-0","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T02:37:18Z","timestamp":1776047838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical value of intraoperative frozen section examination-assisted strategy in prostate biopsy: a comparative study of diagnostic efficiency and clinical practicality"],"prefix":"10.1186","volume":"26","author":[{"given":"Yang","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-quan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-bao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-zhan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-fei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"1","key":"15960_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"15960_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584\u201390.","journal-title":"Chin Med J"},{"key":"15960_CR3","doi-asserted-by":"publisher","first-page":"215927","DOI":"10.1016\/j.canlet.2022.215927","volume":"550","author":"J Liu","year":"2022","unstructured":"Liu J, Dong L, Zhu Y, Dong B, Sha J, Zhu HH, et al. Prostate cancer treatment - China\u2019s perspective. Cancer Lett. 2022;550:215927.","journal-title":"Cancer Lett"},{"issue":"11","key":"15960_CR4","first-page":"801","volume":"43","author":"Chinese Urological Association","year":"2022","unstructured":"Chinese Urological Association, Chinese Prostate Cancer Consortium. Expert consensus on prostate biopsy in China (2022 Edition). Chin J Urol. 2022;43(11):801\u20136.","journal-title":"Chin J Urol"},{"issue":"2","key":"15960_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363.","journal-title":"Eur Urol."},{"issue":"6","key":"15960_CR6","first-page":"428","volume":"99","author":"F Wang","year":"2019","unstructured":"Wang F, Ding XF, Xu JN, Xu YZ, Zhou YQ, Luan Y, et al. Complications of transperineal template-guided prostate mapping biopsy. Chin Med J. 2019;99(6):428\u201331.","journal-title":"Chin Med J"},{"issue":"11","key":"15960_CR7","first-page":"842","volume":"39","author":"XF Ding","year":"2018","unstructured":"Ding XF, Luan Y, Wang F, Xu YZ, Xu JN, Zhou YQ, et al. Research on the influencing factors of periprostatic nerve block anaesthesia. Chin J Urol. 2018;39(11):842\u20136.","journal-title":"Chin J Urol"},{"key":"15960_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.euros.2024.05.009","volume":"66","author":"F Zattoni","year":"2024","unstructured":"Zattoni F, Fasulo V, Kasivisvanathan V, Kesch C, Marra G, Martini A, et al. Enhancing prostate cancer detection accuracy in magnetic resonance imaging-targeted prostate biopsy: optimizing the number of cores taken. Eur Urol Open Sci. 2024;66:16\u201325.","journal-title":"Eur Urol Open Sci"},{"issue":"4","key":"15960_CR9","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.21037\/qims-21-473","volume":"12","author":"XF Ding","year":"2022","unstructured":"Ding XF, Luan Y, Zhu LY, Xiao Q, Chen J, Chen HP, et al. The application of intraoperative frozen section examination in multiparametric magnetic resonance imaging\/transrectal ultrasound fusion prostate biopsy during a major pandemic. Quant Imaging Med Surg. 2022;12(4):2378\u201384.","journal-title":"Quant Imaging Med Surg"},{"key":"15960_CR10","doi-asserted-by":"publisher","first-page":"983805","DOI":"10.3389\/fonc.2022.983805","volume":"12","author":"Y Luan","year":"2022","unstructured":"Luan Y, Xiao Q, Ding XF, Zhu LY, Han YX, Chen HP, et al. Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer. Front Oncol. 2022;12:983805.","journal-title":"Front Oncol"},{"issue":"11","key":"15960_CR11","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.21037\/qims-20-369","volume":"10","author":"XF Ding","year":"2020","unstructured":"Ding XF, Luan Y, Wang F, Xu YZ, Guo CH, Zhu LY. The application of a targeted periprostatic nerve block in transperineal template-guided prostate biopsies. Quant Imaging Med Surg. 2020;10(11):2125\u201332.","journal-title":"Quant Imaging Med Surg"},{"issue":"010","key":"15960_CR12","first-page":"763","volume":"040","author":"XF Ding","year":"2019","unstructured":"Ding XF, Luan Y, Wang F, Xu YZ, Huang TB, Guo CH, et al. Application of modified transperineal template- guided prostate biopsy in the diagnosis of prostate cancer. Chin J Urol. 2019;040(010):763\u20137.","journal-title":"Chin J Urol"},{"issue":"12","key":"15960_CR13","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3390\/medicina58121821","volume":"58","author":"Y Luan","year":"2022","unstructured":"Luan Y, Ding XF, Lu SM, Huang TB, Chen J, Xiao Q, et al. The efficacy of urinary continence in patients undergoing robot-assisted radical prostatectomy with bladder-prostatic muscle reconstruction and bladder neck eversion anastomosis. Medicina (Kaunas). 2022;58(12):1821.","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"15960_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/end.2011.0344","volume":"26","author":"I Tufek","year":"2012","unstructured":"Tufek I, Akpinar H, Atug F, Obek C, Esen HE, Keskin MS, et al. The impact of local anesthetic volume and concentration on pain during prostate biopsy: a prospective randomized trial. J Endourol Endourolo Soc. 2012;26(2):174\u20137.","journal-title":"J Endourol Endourolo Soc"},{"issue":"1","key":"15960_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12894-021-00840-5","volume":"21","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhou Z, Zhou Y, Wu X, Xiao Y, Ji Z, et al. Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy. BMC Urol. 2021;21(1):68.","journal-title":"BMC Urol"},{"issue":"1","key":"15960_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12885-025-14203-y","volume":"25","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wei C, Chen F, Zhang Y, Pu F. Comparing the biopsy strategies of prostate cancer: a systematic review and network meta-analysis. BMC Cancer. 2025;25(1):786.","journal-title":"BMC Cancer"},{"issue":"2","key":"15960_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MOU.0000000000000031","volume":"24","author":"MA Bjurlin","year":"2014","unstructured":"Bjurlin MA, Taneja SS. Standards for prostate biopsy. Curr Opin Urol. 2014;24(2):155\u201361.","journal-title":"Curr Opin Urol"},{"issue":"1","key":"15960_CR18","doi-asserted-by":"publisher","first-page":"14951","DOI":"10.1038\/s41598-024-65354-0","volume":"14","author":"H Sherafatmandjoo","year":"2024","unstructured":"Sherafatmandjoo H, Safaei AA, Ghaderi F, Allameh F. Prostate cancer diagnosis based on multi-parametric MRI, clinical and pathological factors using deep learning. Sci Rep. 2024;14(1):14951.","journal-title":"Sci Rep"},{"issue":"4","key":"15960_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10334-022-01006-6","volume":"35","author":"MC Fernandes","year":"2022","unstructured":"Fernandes MC, Yildirim O, Woo S. The role of MRI in prostate cancer: current and future directions. Magn Reson Mater Phys Biol Med. 2022;35(4):503\u201321.","journal-title":"Magn Reson Mater Phys Biol Med"},{"issue":"17","key":"15960_CR20","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/diagnostics14171864","volume":"14","author":"G Rebez","year":"2024","unstructured":"Rebez G, Barbiero M, Simonato FA. Targeted prostate biopsy: how, when, and why? A systematic review. Diagnostics. 2024;14(17):1864.","journal-title":"Diagnostics."},{"issue":"2","key":"15960_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.15386\/mpr-1784","volume":"94","author":"ED Cata","year":"2021","unstructured":"Cata ED, Andras I, Telecan T, Tamas-Szora A, Coman RT, Stanca DV, et al. MRI-targeted prostate biopsy: the next step forward! Med Pharm Rep. 2021;94(2):145\u201357.","journal-title":"Med Pharm Rep"},{"issue":"6","key":"15960_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.euo.2024.07.009","volume":"7","author":"F Zattoni","year":"2024","unstructured":"Zattoni F, Rajwa P, Miszczyk M, Fazekas T, Carletti F, Carrozza S, et al. Transperineal versus transrectal magnetic resonance imaging-targeted prostate biopsy: a systematic review and meta-analysis of prospective studies. Eur Urol Oncol. 2024;7(6):1303\u201312.","journal-title":"Eur Urol Oncol"},{"issue":"8","key":"15960_CR23","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00259-019-04620-0","volume":"47","author":"P Donato","year":"2020","unstructured":"Donato P, Morton A, Yaxley J, Ranasinghe S, Teloken PE, Kyle S, et al. (68)Ga-PSMA PET\/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is (68)Ga-PSMA PET\/CT guided biopsy the future? Eur J Nucl Med Mol Imaging. 2020;47(8):1843\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"15960_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urology.2022.07.030","volume":"169","author":"Y Okabe","year":"2022","unstructured":"Okabe Y, Patel HD, Rac G, Gupta GN. Multifocality of prostate cancer and candidacy for focal therapy based on magnetic resonance imaging. Urology. 2022;169:141\u20139.","journal-title":"Urology"},{"key":"15960_CR25","doi-asserted-by":"crossref","unstructured":"Liu W, Kadier A, Tang C, Shen D, He Y, Zhu K, et al. Comparison of combined MRI-TRUS fusion targeted and systematic biopsy vs systematic biopsy alone for the detection of prostate cancer in the Chinese biopsy-na\u00efve patients: a prospective, single-center trial. Int J Surg. 2025.","DOI":"10.1097\/JS9.0000000000004037"},{"issue":"2","key":"15960_CR26","doi-asserted-by":"publisher","first-page":"e13257","DOI":"10.5812\/iranjradiol.13257","volume":"12","author":"M Ghafoori","year":"2015","unstructured":"Ghafoori M, Velayati M, Aliyari Ghasabeh M, Shakiba M, Alavi M. Prostate biopsy using transrectal ultrasonography; the optimal number of cores regarding cancer detection rate and complications. Iran J Radiol. 2015;12(2):e13257.","journal-title":"Iran J Radiol"},{"issue":"4","key":"15960_CR27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jamcollsurg.2018.12.002","volume":"228","author":"R Mallick","year":"2019","unstructured":"Mallick R, Stevens TM, Winokur TS, Asban A, Wang TN, Lindeman BM, et al. Is frozen-section analysis during thyroid operation useful in the era of molecular testing? J Am Coll Surg. 2019;228(4):474\u20139.","journal-title":"J Am Coll Surg"},{"issue":"11","key":"15960_CR28","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/PAS.0000000000001138","volume":"42","author":"A Gagne","year":"2018","unstructured":"Gagne A, Racine E, Orain M, Meziou S, Simard S, Couture C, et al. Identification of grossing criteria for intraoperative evaluation by frozen section of lung cancer resection margins. Am J Surg Pathol. 2018;42(11):1495\u2013502.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"15960_CR29","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1245\/s10434-020-08955-z","volume":"28","author":"T Tamanuki","year":"2021","unstructured":"Tamanuki T, Namura M, Aoyagi T, Shimizu S, Suwa T, Matsuzaki H. Effect of intraoperative imprint cytology followed by frozen section on margin assessment in breast-conserving surgery. Ann Surg Oncol. 2021;28(3):1338\u201346.","journal-title":"Ann Surg Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15960-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:53:38Z","timestamp":1781646818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15960-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15960"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15960-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Northern Jiangsu People's Hospital Affiliated to Yangzhou University. Written informed consent was obtained from all participants prior to surgery. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"646"}}